Fig. 2. Histopathological changes in the liver tissue of different groups. (a) Liver in the control group (CNT) showing normal structure; (b) carcinogen control (CC) group showing bile duct hyperplasia (star), karyomegaly (arrow) and degenerative changes; (c, d) liver tissue in groups treated with 10 mg and 20 mg, respectively; (e) mean score of degenerative changes in different groups; (f) picrosirius-stained normal liver with minimal fibrous tissue; (g) fibrous tissue deposition in CC group, (h) 10 mg kg^–1 group, and (i) 20 mg kg^–1 group; (j) mean fibrotic area (%) in livers of different groups. p < 0.05 as compared to CC.